Inhalational anesthetic sevoflurane rescues retina function in Alzheimer's disease transgenic Drosophila

Current Alzheimer Research

Volumn 10, Issue 9, 2013, Pages 1005-1014

  Chen, Chia Wen ^a,b   Lin, Wei Yong ^a   Chen, Kuen Bao ^b   Wu, Yih Shyuan ^a   Kuo, Yu Cheng ^a,b   Liu, Hsin Ping ^a   Li, Chi Yuan ^a,b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

amyloid protein; Alzheimer's disease; Drosophila; Inhalational anesthetics; Sevoflurane

Indexed keywords

SEVOFLURANE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLIMBING; CONTROLLED STUDY; ELECTRORETINOGRAM; FRUIT FLY MODEL; IMMUNOHISTOCHEMISTRY; MALE; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; RETINA; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

ALZHEIMER DISEASE; ANESTHETICS, INHALATION; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BRAIN; DROSOPHILA; METHYL ETHERS; NEUROPROTECTIVE AGENTS; RETINA;

EID: 84888230837     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/15672050113106660165     Document Type: Article

References (48)

1. Backman L, Jones S, Berger AK, Laukka EJ, Small BJ. Multiple cognitive deficits during the transition to Alzheimer's disease. J Int Med 256: 195-204 (2004).
2. Arnaiz E, Almkvist O. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurol Scan Suppl 179: 34-41 (2003).
3. Poletti M, Enrici I, Adenzato M. Cognitive and affective Theory of Mind in neurodegenerative diseases: neuropsychological, neuroanatomical and neurochemical levels. Neurosci Biobehav Revi 36: 2147-2164 (2012).
4. Yaffe K, Tocco M, Petersen RC, Sigler C, Burns LC, Cornelius C, et al. The epidemiology of Alzheimer's disease: Laying the foundation for drug design, conduct, and analysis of clinical trials. Alzheimer's & Dementia: J Alzheimer Assoc 8: 237-242 (2012).
5. Querfurth HW, LaFerla FM. Alzheimer's disease. New Engl J Med 362: 329-344 (2010).
6. Tanzi RE, Bertram L. Alzheimer's disease: The latest suspect. Nature 454: 706-708 (2008).
7. Tanzi RE, Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120: 545-555 (2005).
8. Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Bio Res Com 122: 1131-1135 (1984).
9. Culley DJ, Xie Z, Crosby G. General anesthetic-induced neurotoxicity: an emerging problem for the young and old? Curr Opin Anaesth 20: 408-413 (2007).
10. Hocker J, Stapelfeldt C, Leiendecker J, Meybohm P, Hanss R, Scholz J, et al. Postoperative neurocognitive dysfunction in elderly patients after xenon versus propofol anesthesia for major noncardiac surgery: a double-blinded randomized controlled pilot study. Anesthesiology 110: 1068-1076 (2009).
11. Moller JT, Cluitmans P, Rasmussen LS, Houx P, Rasmussen H, Canet J, et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 351: 857-861 (1998).
12. Satomoto M, Satoh Y, Terui K, Miyao H, Takishima K, Ito M, et al. Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology 110: 628-637 (2009).
13. Edwards DA, Shah HP, Cao W, Gravenstein N, Seubert CN, Martynyuk AE. Bumetanide alleviates epileptogenic and neurotoxic effects of sevoflurane in neonatal rat brain. Anesthesiology 112: 567-575 (2010).
14. Dong Y, Zhang G, Zhang B, Moir RD, Xia W, Marcantonio ER, et al. The common inhalational anesthetic sevoflurane induces apoptosis and increases beta-amyloid protein levels. Arch Neurol 66: 620-631 (2009).
15. Kvolik S, Glavas-Obrovac L, Bares V, Karner I. Effects of inhalation anesthetics halothane, sevoflurane, and isoflurane on human cell lines. Life Sci 77: 2369-2383 (2005).
16. Bohnen N, Warner MA, Kokmen E, Kurland LT. Early and midlife exposure to anesthesia and age of onset of Alzheimer's disease. Int J Neurosci 77: 181-185 (1994).
17. Ye Z, Huang YM, Wang E, Zuo ZY, Guo QL. Sevoflurane-induced delayed neuroprotection involves mitoK(ATP) channel opening and PKC epsilon activation. Mol Biol Rep 39: 5049-5057 (2012).
18. Onishi A, Miyamae M, Kaneda K, Kotani J, Figueredo VM. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A. Eur J Pharmacol 675: 40-46 (2012).
19. Seitz DP, Shah PS, Herrmann N, Beyene J, Siddiqui N. Exposure to general anesthesia and risk of Alzheimer's disease: a systematic review and meta-analysis. BMC Geriatrics 11: 83 (2011).
20. Reiter LT, Potocki L, Chien S, Gribskov M, Bier E. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res 11: 1114-1125 (2001).
21. Ambegaokar SS, Roy B, Jackson GR. Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis. Neurobiol Dis 40: 29-39 (2010).
22. Bonner JM, Boulianne GL. Drosophila as a model to study age-related neurodegenerative disorders: Alzheimer's disease. Exp Gerontol 46: 335-339 (2011).
23. Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, Zhong Y. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc Natil Acad Sci USA 101: 6623-6628 (2004).
24. Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118: 01-15 (1993).
25. Lu Y, Wu X, Dong Y, Xu Z, Zhang Y, Xie Z. Anesthetic sevoflurane causes neurotoxicity differently in neonatal naive and Alzheimer disease transgenic mice. Anesthesiology 112: 1404-1416 (2010).
26. Rajaram S, Scott RL, Nash HA. Retrograde signaling from the brain to the retina modulates the termination of the light response in Drosophila. Proc Natl Acad Sci USA 102: 17840-17845 (2005).
27. Feany MB, Bender WW. A Drosophila model of Parkinson's disease. Nature 404: 394-398 (2000).
28. Li YM, Chan HY, Yao XQ, Huang Y, Chen ZY. Green tea catechins and broccoli reduce fat-induced mortality in Drosophila melanogaster. J Nutr Biochem 19: 376-383(2008).
29. Stucke AG, Zuperku EJ, Krolo M, Brandes IF, Hopp FA, Kampine JP, et al. Sevoflurane enhances gamma-aminobutyric acid type A receptor function and overall inhibition of inspiratory premotor neurons in a decerebrate dog model. Anesthesiology 103: 57-64 (2005).
30. Nishikawa K, Kubo K, Ishizeki J, Takazawa T, Saito S, Goto F. The interaction of noradrenaline with sevoflurane on GABA(A) receptor-mediated inhibitory postsynaptic currents in the rat hippocampus. Brain Res 1039: 153-161 (2005).
31. Kolodziejczyk A, Sun X, Meinertzhagen IA, Nassel DR. Glutamate, GABA and acetylcholine signaling components in the lamina of the Drosophila visual system. PloS One 3: 2110 (2008).
32. Cirrito JR, Disabato BM, Restivo JL, Verges DK, Goebel WD, Sathyan A, et al. Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans. Proc Natl Acad Sci USA 108: 14968-14973 (2011).
33. Ogasawara H, Takahashi S, Kudo T, Kudo M, Ishihara H, Matsuki A. Effects of sevoflurane anesthesia on serotonin metabolism in rat brain. Masui 42: 1412-1417 (1993)).
34. Koronyo Y, Salumbides BC, Black KL, Koronyo-Hamaoui M. Alzheimer's disease in the retina: imaging retinal abeta plaques for early diagnosis and therapy assessment. Neurodegener Dis 10: 285-293 (2012).
35. Paula-Lima AC, Louzada PR, De Mello FG, Ferreira ST. Neuroprotection against Abeta and glutamate toxicity by melatonin: are GABA receptors involved? Neurotox Res 5: 323-327(2003).
36. Louzada PR, Paula Lima AC, Mendonca-Silva DL, Noel F, De Mello FG, Ferreira ST. Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders. FASEB J 18: 511-518 (2004).
37. Rudolph U, Antkowiak B. Molecular and neuronal substrates for general anaesthetics. Nature Reviews. Neuroscience 5: 709-720 (2004).
38. Cossart R, Bernard C, Ben-Ari Y. Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies. Trends Neurosci 28: 108-115 (2005).
39. Croisile B, Auriacombe S, Etcharry-Bouyx F, Vercelletto M. The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia. Rev Neurol (2012).
40. Stratmann G, Sall JW, Bell JS, Alvi RS, May LV, Ku B, et al. Isoflurane does not affect brain cell death, hippocampal neurogenesis, or long-term neurocognitive outcome in aged rats. Anesthesiology 112: 305-315 (2010).
41. Eckenhoff RG, Johansson JS, Wei H, Carnini A, Kang B, Wei W, et al. Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology 101: 703-709 (2004).
42. Eckenhoff RG, Johansson JS, Wei H, Carnini A, Kang B, Wei W, et al. Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology 101: 703-709 (2004).
43. Xie Z, Dong Y, Maeda U, Moir RD, Xia W, Culley DJ, et al. The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. J Neurosci 27: 1247-1254 (2007).
44. Wei H, Liang G, Yang H. Isoflurane preconditioning inhibited isoflurane-induced neurotoxicity. Neurosci Lett 425: 59-62 (2007).
45. Yang Q, Dong H, Deng J, Wang Q, Ye R, Li X, et al. Sevoflurane preconditioning induces neuroprotection through reactive oxygen species-mediated up-regulation of antioxidant enzymes in rats. Anesth Analg 112: 931-937 (2011).
46. Lin D, Li G, Zuo Z. Volatile anesthetic post-treatment induces protection via inhibition of glycogen synthase kinase 3beta in human neuron-like cells. Neuroscience 179: 73-79(2011).
47. Xu Z, Dong Y, Wu X, Zhang J, McAuliffe S, Pan C, et al. The potential dual effects of anesthetic isoflurane on Abeta-induced apoptosis. Curr Alzheimer Res 8: 741-752 (2011).
48. Wang QJ, Li KZ, Yao SL, Li ZH, Liu SS. Different effects of isoflurane and sevoflurane on cytotoxicity. Chin Med J 121: 341-346 (2008).